PI
VNRX icon

PFG Investments’s VolitionRx Ltd VNRX Stock Holding History

PFG Investments’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05K Buy
+1,250
New +$5.97K ﹤0.01% 1188

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

PFG Investments's VNRX Position: Q1 2026 in Review

PFG Investments opened a new position in VolitionRx Ltd (VNRX) in Q1 2026: 1,250 shares worth $5.05K. The stake represents ﹤0.01% of the portfolio and ranks #1188 among its holdings.

31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • PFG Investments held 1,250 shares of VolitionRx Ltd worth $5.05K as of Q1 2026.
  • VolitionRx Ltd was a new PFG Investments position in Q1 2026.
  • VolitionRx Ltd made up ﹤0.01% of PFG Investments's portfolio in Q1 2026, its #1188 holding.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.